<DOC>
	<DOC>NCT01903486</DOC>
	<brief_summary>Would systemic steroids be an effective treatment in early variants of achalasia?</brief_summary>
	<brief_title>Assessing the Efficacy of Steroid Treatment of Achalasia</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Achalasia</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Inclusion criteria: Adults ages 1890 with a diagnosis of achalasia confirmed by findings on esophageal manometry and barium esophagogram will be eligible for the study. Eckardt score6 greater or equal to 6 or 2 or greater for dysphagia and/or regurgitation Symptoms less than 2 years Exclusion criteria: Medical conditions such as severe heart or lung disease that preclude safe performance of endoscopy and injection; Greater than mild esophageal dilation Type 1 achalasia as defined by the Chicago classification scheme7 and/or esophageal diameter &gt; 3cm; Prior treatment for achalasia Use of medications that might affect LES pressure such as anticholinergics or calcium channel antagonists Symptom duration greater than 2 years Inability to read due to: Blindness, cognitive dysfunction, or English language illiteracy Disorders which predispose to unreliable responses such as Schizophrenia, Alzheimer's disease or significant memory loss Pregnant and lactating females will be excluded as steroids are not thought safe for the fetus.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Trouble swallowing</keyword>
	<keyword>dysphagia</keyword>
	<keyword>disorder of the esophagus</keyword>
</DOC>